Multiomics Network Medicine Approaches to Precision Medicine and Therapeutics in Cardiovascular Diseases
Arteriosclerosis, Thrombosis, and Vascular Biology · 2023-04 · 43 (4) · 493-503
DOI: 10.1161/atvbaha.122.318731 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2023-04. Verfasst von Rui-Sheng Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine (R.-S.W., B.A.M., J.L.), Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Hauptthemen laut MEDLINE: Precision Medicine, Cardiovascular Diseases. Die Arbeit wurde bisher 125-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, NHLBI NIH HHS, American Heart Association-American Stroke Association.
Abstract (Originalsprache)
Cardiovascular diseases (CVD) are the leading cause of death worldwide and display complex phenotypic heterogeneity caused by many convergent processes, including interactions between genetic variation and environmental factors. Despite the identification of a large number of associated genes and genetic loci, the precise mechanisms by which these genes systematically influence the phenotypic heterogeneity of CVD are not well understood. In addition to DNA sequence, understanding the molecular mechanisms of CVD requires data from other omics levels, including the epigenome, the transcriptome, the proteome, as well as the metabolome. Recent advances in multiomics technologies have opened new precision medicine opportunities beyond genomics that can guide precise diagnosis and personalized treatment. At the same time, network medicine has emerged as an interdisciplinary field that integrates systems biology and network science to focus on the interactions among biological components in health and disease, providing an unbiased framework through which to integrate systematically these multiomics data. In this review, we briefly present such multiomics technologies, including bulk omics and single-cell omics technologies, and discuss how they can contribute to precision medicine. We then highlight network medicine-based integration of multiomics data for precision medicine and therapeutics in CVD. We also include a discussion of current challenges, potential limitations, and future directions in the study of CVD using multiomics network medicine approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine (R.-S.W., B.A.M., J.L.), Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
- Channing Division of Network Medicine (R.-S.W., J.L.), Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
ORCID-Profile: Bradley A Maron, Joseph Loscalzo
Förderung
- NHGRI NIH HHS
- NHLBI NIH HHS
- American Heart Association-American Stroke Association
Zitieren
APA
Wang, R. S., Maron, B. A., & Loscalzo, J. (2023). Multiomics Network Medicine Approaches to Precision Medicine and Therapeutics in Cardiovascular Diseases. Arteriosclerosis, Thrombosis, and Vascular Biology, 43(4), 493-503. https://doi.org/10.1161/atvbaha.122.318731
Vancouver
Wang RS, Maron BA, Loscalzo J. Multiomics Network Medicine Approaches to Precision Medicine and Therapeutics in Cardiovascular Diseases. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023;43(4):493-503. doi:10.1161/atvbaha.122.318731
BibTeX
@article{Wang2023,
author = {Wang, Rui-Sheng and Maron, Bradley A and Loscalzo, Joseph},
title = {Multiomics Network Medicine Approaches to Precision Medicine and Therapeutics in Cardiovascular Diseases},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2023},
volume = {43},
number = {4},
pages = {493--503},
doi = {10.1161/atvbaha.122.318731}
}
EUVIMED